{"name":"Jonathan A. Javitch, MD, PhD","slug":"jonathan-a-javitch-md-phd","ticker":"","exchange":"","domain":"","description":"Jonathan A. Javitch, MD, PhD is a clinical researcher and physician with expertise in psychiatry and neuropharmacology, focusing on the development and clinical application of novel treatments for mental health disorders.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Tianeptine Sodium","genericName":"Tianeptine Sodium","slug":"tianeptine-sodium","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Tianeptine Sodium","genericName":"Tianeptine Sodium","slug":"tianeptine-sodium","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNdTRrUjRpQTdDTC1yenBCSl8zNUNvdGgzRzVlNk9oMXQ3ekVRYllUVnlodDNuMm5tc0RMNXBheFRERGVoM0tTUmFtdVRWZFFUNTRGVWNMSDRQMGRpd2hlRXZjZXloQ3FSc0RCZUxLT1JvbVJYdkxqdkpScjFtU0hyOVluWVByb0VrV3B1WjljUVhHeGxHbWRDa3dPM3B4dWdUYUp5U28zNGJobkw3ZGlaUkF0a05WWjdvbW5HUmZUZzRSMUtxMzRtdWVXMDI?oc=5","date":"2020-07-09","type":"pipeline","source":"BioSpace","summary":"ATAI Life Sciences takes on opioid crisis by acquiring Kures to develop novel therapeutics for opioid abuse - BioSpace","headline":"ATAI Life Sciences takes on opioid crisis by acquiring Kures to develop novel therapeutics for opioid abuse","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}